Zobrazeno 1 - 10
of 37
pro vyhledávání: '"L A, Shabalova"'
Autor:
V. D. Sherman, E. I. Kondratieva, A. Y. Voronkova, N. Y. Kashirskaya, L. A. Shabalova, V. S. Nikonova, E. K. Zhekaite, S. I. Kutsev
Publikováno v:
Медицинский совет, Vol 0, Iss 18, Pp 124-128 (2017)
Study objective: comparative evaluation of clinical status of patients with cystic fibrosis (CF) 6–9 years, the diagnosis of which was established before the start of neonatal screening (NS) for MV in the Moscow region and in same age group since t
Externí odkaz:
https://doaj.org/article/946811a28f8543908e247106ef41bf70
Autor:
S. V. POLIKARPOVA, E. I. KONDRATYEVA, L. A. SHABALOVA, N. V. PIVKINA, S. V. ZHILINA, A. Y. VORONKOVA, V. D. SHERMAN, V. S. NIKONOVA, N. I. KAPRANOV, N. Y. KASHIRSKAYA, S. Y. SEMYKIN, E. L. AMELINA, S. A. KRASOVSKY
Publikováno v:
Медицинский совет, Vol 0, Iss 15, Pp 84-89 (2016)
Chronic lower respiratory tract infection in patients with cystic fibrosis (CF) is the major factor determining the severity of the clinical course and prognosis of the disease. The purpose of the study was to investigate the prevailing respiratory m
Externí odkaz:
https://doaj.org/article/9fde4088c52346b292623b7a73c2d83c
Autor:
N. Yu. Kashirskaya, S. A. Krasovsky, A. V. Chernyak, V. D. Sherman, A. Yu. Voronkova, L. A. Shabalova, V. S. Nikonova, Yu. V. Gorinova, O. I. Simonova, E. L. Amelina, E. I. Kondrat’eva, N. I. Kapranov, N. V. Petrova, R. A. Zinchenko
Publikováno v:
Вопросы современной педиатрии, Vol 14, Iss 4, Pp 503-508 (2015)
Cystic fibrosis is multiple organ pathology that requires a complex treatment. Its standardization and pharmacoeconomic analysis are absolutely necessary. We performed a retrospective analysis of the trends in life expectancy of cystic fibrosis patie
Externí odkaz:
https://doaj.org/article/469ac005c5ab44a3b76219cbd0d47e2f
Autor:
Ye. L. Amelina, I. K. Asherova, I. K. Volkov, Т. Ye. Gembitskaya, Ye. K. Ginter, N. А. Il’yenkova, N. I. Kapranov, I. P. Karimova, N. Yu. Kashirskaya, Ye. I. Kondrat’yeva, М. N. Kostyleva, S. А. Krasovsky, N. B. Merzlova, L. P. Nazarenko, L. S. Namazova-Baranova, А. F. Neretina, V. S. Nikonova, А. V. Orlov, S. S. Postnikov, Т. А. Protasova, S. Yu. Semykin, D. F. Sergienko, О. I. Simonova, I. D. Uspenskaya, М. Yu. Chernukha, L. А. Shabalova, I. А. Shaginyan, V. D. Sherman
Publikováno v:
Вопросы современной педиатрии, Vol 13, Iss 6, Pp 89-95 (2014)
The pulmonary drug administration for the treatment of a pulmonary affection in cystic fibrosis is highly effective. This consensus document summarizes data on inhalation intake of bronchodilators, mucolytics, anti-inflammatory drugs, including gluco
Externí odkaz:
https://doaj.org/article/6524667aa0ed4fb08cf3767cd4dcf923
Autor:
S. A. Krasovskii, V. S. Nikonova, N. Yu. Kashirskaya, E. I. Kondrat'eva, A. V. Chernyak, N. I. Kapranov, E. L. Amelina, V. D. Sherman, V. A. Samoilenko, A. Yu. Voronkova, L. A. Shabalova, O. I. Simonova, M. V. Usacheva, V. V. Chernikov
Publikováno v:
Вопросы современной педиатрии, Vol 12, Iss 1, Pp 17-23 (2013)
The aim of this study was to assess different clinical and genetic, microbiological and functional features of patients with cystic fibrosis living in Moscow and Moscow region on the 31st December, 2010. The mean age of the patients was 12,1±9,6 yea
Externí odkaz:
https://doaj.org/article/f51de47f38dc47499787b8f479273248
Autor:
A. L. Pukhalsky, N. I. Kapranov, E. A. Kalashnikova, G. V. Shmarina, L. A. Shabalova, S. N. Kokarovtseva, D. A. Pukhalskaya, N. J. Kashirskaja, O. I. Simonova
Publikováno v:
Mediators of Inflammation, Vol 8, Iss 3, Pp 159-167 (1999)
Chronic endobronchial inflammation and bacterial infection are the main causes of morbidity and mortality in cystic fibrosis (CF), an autosomal recessive genetic disorder associated with improper function of chloride channels. Inflammation in CF lung
Externí odkaz:
https://doaj.org/article/2ed24d686903424a88b9c79ed46cdf57
Autor:
E. I. Kondratyeva, V. D. Sherman, E. L. Amelina, A. Yu. Voronkova, S. A. Krasovsky, N. Yu. Kashirskaya, N. V. Petrova, A. V. Chernyak, N. I. Kapranov, V. S. Nikonova, L. A. Shabalova
Publikováno v:
Rossijskij Vestnik Perinatologii i Pediatrii, Vol 61, Iss 6, Pp 77-81 (2017)
The aim of this study was to investigate the prevalence of meconium ileus in a Russian population of patients with cystic fibrosis, its clinical and genetic characteristics and outcomes, by analyzing the data available in the 2014 registry of the Rus
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::11ae070ef7c347d394f0b5a69f1b2766
https://www.ped-perinatology.ru/jour/article/view/419
https://www.ped-perinatology.ru/jour/article/view/419
Autor:
L. А. Shabalova, N.Yu. Kashirskaya, S. Yu. Semykin, L. S. Namazova-Baranova, А. V. Orlov, V.D. Sherman, М. Yu. Chernukha, Т. Ye. Gembitskaya, I. Asherova, S.S. Postnikov, Ye. K. Ginter, N. А. Il’yenkova, Т. А. Protasova, Ye. L. Amelina, I. P. Karimova, М. N. Kostyleva, I. D. Uspenskaya, D. Sergienko, А. F. Neretina, Ye. I. Kondrat’yeva, I. А. Shaginyan, I. K. Volkov, N. Kapranov, L. P. Nazarenko, О. I. Simonova, N. B. Merzlova, V.S. Nikonova, S. Krasovsky
Publikováno v:
Voprosy Sovremennoj Pediatrii, Vol 13, Iss 6, Pp 89-95 (2014)
The pulmonary drug administration for the treatment of a pulmonary affection in cystic fibrosis is highly effective. This consensus document summarizes data on inhalation intake of bronchodilators, mucolytics, anti-inflammatory drugs, including gluco
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4361180b91c552b33415e41b59db87a3
https://vsp.spr-journal.ru/jour/article/view/109
https://vsp.spr-journal.ru/jour/article/view/109
Autor:
N I, Kapranov, L A, Shabalova, N Iu, Kashirskaia, O I, SimonovaO, A Iu, Voronkova, I A, Osipova, S Iu, Semykin, S V, Polikarpova, S S, Postnikov
Publikováno v:
Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic]. 46(2)
It is postulated that P. aeruginosa in monoculture or in association with Staphylococcus aureus keeps its leading position in chronic bacterial inflammatory broncho-pulmonary processes in children with cystic fibrosis. Antibiotic resistant strains of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::1eea0d877eba974de2e8af4132cfef10
https://pubmed.ncbi.nlm.nih.gov/11544748
https://pubmed.ncbi.nlm.nih.gov/11544748
Autor:
N I, Kapranov, T E, Gembitskaia, O I, Simonova, E L, Amelina, L F, Kovaleva, L A, Shabalova, N Iu, Kashirskaia, M E, Faustova
Publikováno v:
Terapevticheskii arkhiv. 73(1)
To study clinical effectiveness and safety of a new mucolytic drug pulmozim (Switzerland) adjuvant to basic therapy in mucoviscidosis patients of different age in Russia.15 patients with mucoviscidosis aged 5-36 years, functional lung capacity and FE
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::4e3b38fdc988cc07716863e006d109b0
https://pubmed.ncbi.nlm.nih.gov/11234144
https://pubmed.ncbi.nlm.nih.gov/11234144